Explore detailed financial insights for NSE: Alkyl Amines Chemicals Limited, including share price, quarterly results, governance, and stock forecasts for 2025.

NSE: Alkyl Amines Chemicals Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept

Stay informed with the latest announcements for Alkylamine, including updates on board meetings and corporate actions.

ALKYLAMINE
Alkyl Amines Chemicals Limited - https://alkylamines.com
Alkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. The company offers aliphatic amine products, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydrochloride, triethylamine hydrochloride, 3-ethoxy propylamine, 3-(methylaminopropyl) amine, dimethylaminopropylamine, 3-(2-ethylhexyloxy) propylamine, n-methylbenzylamine, diisopropyl ethylamine, diethylhydroxylamine, diethyl toluamide, and diethylphenyl acetamide. It also provides specialty chemicals, such as acetonitrile; 1,8-diazabicyclo[5.4.0]undec-7-ene; diethylketone/3-pentanone; alchan 100; alchan 300; 2-aminoethoxy ethanol; 2-ethoxy ethylamine; dimethylpropyleneurea; tetramethyl ethylenediamine; monomethylamine; and tempo, free radical. The company serves pharmaceutical, agrochemical, water treatment, rubber chemical, and other industries. Alkyl Amines Chemicals Limited was incorporated in 1979 and is headquartered in Navi Mumbai, India.

Alkyl Amines Chemicals Limited Share Price Today

1,689.85
OPEN
1,719.95
HIGH
1,680.95
LOW
1,701.20
CLOSE
32 K
VOLUME
9,578 Cr
Market Cap
57741
Average Volume
Basic Materials
Sector
NSI
Exchange

Alkyl Amines Chemicals Limited Share Analysis & 2025 Insights

// -->

Investor Presentations

Date Description Download
SIP
Lumpsum
₹25,000
12%
10 Yr

Invested Amount: ₹

Estimated Returns: ₹

Total Value: ₹

NSE: ALKYLAMINE Stock Actions

Company
Symbol
ISIN
Subject
Ex Date
Face Value
Broadcast Date
Alkyl Amines Chemicals Limited
ALKYLAMINE
INE150B01013
Annual General Meeting/Dividend - Rs 10 Per Share
25 Jun 2024
2
N/A
Alkyl Amines Chemicals Limited
ALKYLAMINE
INE150B01013
Annual General Meeting/Dividend - Rs 10 Per Share
04 Jul 2023
2
N/A
Alkyl Amines Chemicals Limited
ALKYLAMINE
INE150B01013
Annual General Meeting/Dividend - Rs 10 Per Share
22 Jul 2022
2
N/A
Alkyl Amines Chemicals Limited
ALKYLAMINE
INE150B01013
Annual General Meeting/Dividend - Rs 6 Per Share
12 Jul 2021
2
N/A
Alkyl Amines Chemicals Limited
ALKYLAMINE
INE150B01013
Face Value Split (Sub-Division) - From Rs 5/- Per Share To Rs 2/- Per Share
11 May 2021
2
N/A

NSE: ALKYLAMINE Recent Announcements

Symbol
Date
Description
Industry
ALKYLAMINE
01 Jan 2025, 13:10:38
Updates
Chemicals - Speciality
ALKYLAMINE
29 Dec 2024, 12:51:34
Disruption of Operations
Chemicals - Speciality
ALKYLAMINE
26 Dec 2024, 18:16:31
Trading Window-XBRL
Chemicals - Speciality
ALKYLAMINE
26 Dec 2024, 18:07:03
Trading Window
Chemicals - Speciality
ALKYLAMINE
04 Dec 2024, 17:37:07
Loss/Duplicate-Share Certificate-XBRL
Chemicals - Speciality

NSE: ALKYLAMINE Corporate Governance

Name
Symbol
Timestamp
Submission Date
XBRL Document
Alkyl Amines Chemicals Limited
ALKYLAMINE
16 Oct 2024, 13:29:00
16 Oct 2024, 13:29:00
Alkyl Amines Chemicals Limited
ALKYLAMINE
15 Jul 2024, 17:36:00
15 Jul 2024, 17:36:00
Alkyl Amines Chemicals Limited
ALKYLAMINE
19 Apr 2024, 17:23:00
19 Apr 2024, 17:45:00
Alkyl Amines Chemicals Limited
ALKYLAMINE
16 Jan 2024, 12:00:00
16 Jan 2024, 12:30:00
Alkyl Amines Chemicals Limited
ALKYLAMINE
18 Oct 2023, 18:45:00
18 Oct 2023, 19:15:00

NSE: ALKYLAMINE Detailed Governance

Category
Date of Birth
Date of Initial Appointment
DIN
Director Name
Status
Chairperson Related To Promoters,Executive Director-MD
20 Feb 1949
17 Oct 1979
00010015
Yogesh M. Kothari
Active
Executive Director
13 Sep 1952
17 Dec 1996
00019239
Kirat Patel
Active
Executive Director
17 Jun 1976
24 Jan 2007
00021421
Suneet Y. Kothari
Active
Executive Director
06 Feb 1969
01 Jun 2022
07977008
Rakesh Goyal
Active
Independent Director
02 Nov 1949
18 Oct 1980
00032012
Dilip G. Piramal
Active

NSE: ALKYLAMINE Board Meetings

Purpose
Symbol
Industry
ISIN
Name
Time
ALKYL AMINES CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 .
ALKYLAMINE
N/A
INE150B01013
Alkyl Amines Chemicals Limited
09 Oct 2024, 15:27:26
Financial Results
ALKYLAMINE
N/A
INE150B01013
Alkyl Amines Chemicals Limited
12 Jul 2024, 17:20:42
ALKYL AMINES CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 09-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend.
ALKYLAMINE
N/A
INE150B01013
Alkyl Amines Chemicals Limited
15 Apr 2024, 13:24:03
Financial Results
ALKYLAMINE
N/A
INE150B01013
Alkyl Amines Chemicals Limited
04 Jan 2024, 18:30:02
Financial Results
ALKYLAMINE
N/A
INE150B01013
Alkyl Amines Chemicals Limited
09 Oct 2023, 18:31:02

NSE: ALKYLAMINE Event Calendar

Purpose
Symbol
Industry
ISIN
Name
Time
Description
Financial Results
ALKYLAMINE
-
INE150B01013
Alkyl Amines Chemicals Limited
10 Jan 2025, 00:00:00
To consider and approve the financial results for the period ended December 31, 2024
Financial Results
ALKYLAMINE
-
INE150B01013
Alkyl Amines Chemicals Limited
09 Oct 2024, 00:00:00
To consider and approve the financial results for the period ended September 30, 2024
Financial Results
ALKYLAMINE
-
INE150B01013
Alkyl Amines Chemicals Limited
12 Jul 2024, 00:00:00
To consider and approve the financial results for the period ended Jun 30, 2024
Financial Results/Dividend
ALKYLAMINE
-
INE150B01013
Alkyl Amines Chemicals Limited
15 Apr 2024, 00:00:00
To consider and approve the financial results for the period ended March 31, 2024 and dividend
Financial Results
ALKYLAMINE
-
INE150B01013
Alkyl Amines Chemicals Limited
04 Jan 2024, 00:00:00
To consider and approve the financial results for the period ended December 31, 2023

NSE: ALKYLAMINE Balance Sheet Data In (Cr)

date period_type Treasury Shares Number Ordinary Shares Number Share Issued Net Debt Total Debt Tangible Book Value Invested Capital Working Capital Net Tangible Assets Capital Lease Obligations Common Stock Equity Total Capitalization Total Equity Gross Minority Interest Stockholders Equity Other Equity Interest Retained Earnings Additional Paid In Capital Capital Stock Common Stock Total Liabilities Net Minority Interest Total Non Current Liabilities Net Minority Interest Other Non Current Liabilities Non Current Pension And Other Postretirement Benefit Plans Tradeand Other Payables Non Current Non Current Deferred Revenue Non Current Deferred Taxes Liabilities Long Term Debt And Capital Lease Obligation Long Term Capital Lease Obligation Long Term Debt Long Term Provisions Current Liabilities Other Current Liabilities Current Debt And Capital Lease Obligation Current Capital Lease Obligation Current Debt Pensionand Other Post Retirement Benefit Plans Current Current Provisions Payables Other Payable Dividends Payable Accounts Payable Total Assets Total Non Current Assets Other Non Current Assets Non Current Prepaid Assets Investmentin Financial Assets Available For Sale Securities Goodwill And Other Intangible Assets Other Intangible Assets Net PPE Accumulated Depreciation Gross PPE Construction In Progress Other Properties Machinery Furniture Equipment Buildings And Improvements Land And Improvements Properties Current Assets Other Current Assets Hedging Assets Current Restricted Cash Prepaid Assets Inventory Inventories Adjustments Allowances Other Inventories Finished Goods Work In Process Raw Materials Other Receivables Taxes Receivable Accounts Receivable Allowance For Doubtful Accounts Receivable Gross Accounts Receivable Cash Cash Equivalents And Short Term Investments Other Short Term Investments Cash And Cash Equivalents Cash Equivalents Cash Financial
2024-09-30T00:00:00 quarterly 0.00 51,136,038.00 51,136,038.00 0.00 22,300,000.00 13,087,100,000.00 13,119,600,000.00 2,910,200,000.00 13,087,100,000.00 22,300,000.00 13,119,600,000.00 13,119,600,000.00 13,119,600,000.00 13,119,600,000.00 13,017,200,000.00 0.00 0.00 102,400,000.00 102,400,000.00 3,930,500,000.00 1,353,900,000.00 0.00 0.00 14,000,000.00 397,600,000.00 809,700,000.00 17,400,000.00 17,400,000.00 0.00 115,200,000.00 2,576,600,000.00 121,800,000.00 4,900,000.00 4,900,000.00 0.00 0.00 32,000,000.00 2,044,100,000.00 0.00 0.00 2,044,100,000.00 17,050,100,000.00 11,563,300,000.00 484,700,000.00 0.00 42,200,000.00 42,200,000.00 32,500,000.00 0.00 10,941,800,000.00 0.00 10,941,800,000.00 329,400,000.00 10,612,400,000.00 0.00 0.00 0.00 0.00 5,486,800,000.00 160,700,000.00 0.00 0.00 0.00 1,620,900,000.00 0.00 0.00 0.00 0.00 0.00 1,000,000.00 0.00 2,345,200,000.00 0.00 0.00 1,359,000,000.00 320,600,000.00 1,038,400,000.00 0.00 0.00
2024-03-31T00:00:00 quarterly 0.00 51,121,395.00 51,121,395.00 0.00 31,678,000.00 12,634,074,000.00 12,677,816,000.00 2,154,412,000.00 12,634,074,000.00 25,306,000.00 12,671,444,000.00 12,671,444,000.00 12,671,444,000.00 12,671,444,000.00 37,310,000.00 11,956,146,000.00 205,394,000.00 102,321,000.00 102,321,000.00 3,164,797,000.00 885,654,000.00 0.00 106,866,000.00 20,504,000.00 2,101,000.00 736,964,000.00 19,219,000.00 19,219,000.00 0.00 106,900,000.00 2,279,143,000.00 2,270,000.00 12,459,000.00 6,087,000.00 6,372,000.00 45,268,000.00 36,700,000.00 2,146,564,000.00 417,671,000.00 9,893,000.00 1,719,000,000.00 15,836,241,000.00 11,402,686,000.00 27,107,000.00 60,439,000.00 0.00 42,900,000.00 37,370,000.00 37,370,000.00 11,210,611,000.00 -2,271,054,000.00 13,481,665,000.00 355,733,000.00 547,786,000.00 11,063,205,000.00 1,202,751,000.00 312,190,000.00 0.00 4,433,555,000.00 76,594,000.00 0.00 9,893,000.00 15,587,000.00 1,719,655,000.00 -4,165,000.00 76,665,000.00 836,857,000.00 105,379,000.00 704,919,000.00 16,367,000.00 74,262,000.00 2,217,280,000.00 0.00 2,217,280,000.00 303,917,000.00 151,000.00 303,766,000.00 212,000,000.00 91,766,000.00
2024-03-31T00:00:00 annual 0.00 51,121,395.00 51,121,395.00 0.00 31,678,000.00 12,634,074,000.00 12,677,816,000.00 2,154,412,000.00 12,634,074,000.00 25,306,000.00 12,671,444,000.00 12,671,444,000.00 12,671,444,000.00 12,671,444,000.00 37,310,000.00 11,956,146,000.00 205,394,000.00 102,321,000.00 102,321,000.00 3,164,797,000.00 885,654,000.00 0.00 106,866,000.00 20,504,000.00 2,101,000.00 736,964,000.00 19,219,000.00 19,219,000.00 0.00 106,900,000.00 2,279,143,000.00 2,270,000.00 12,459,000.00 6,087,000.00 6,372,000.00 45,268,000.00 36,700,000.00 2,146,564,000.00 417,671,000.00 9,893,000.00 1,719,000,000.00 15,836,241,000.00 11,402,686,000.00 27,107,000.00 60,439,000.00 0.00 42,900,000.00 37,370,000.00 37,370,000.00 11,210,611,000.00 -2,271,054,000.00 13,481,665,000.00 355,733,000.00 547,786,000.00 11,063,205,000.00 1,202,751,000.00 312,190,000.00 0.00 4,433,555,000.00 76,594,000.00 0.00 9,893,000.00 15,587,000.00 1,719,655,000.00 -4,165,000.00 76,665,000.00 836,857,000.00 105,379,000.00 704,919,000.00 16,367,000.00 74,262,000.00 2,217,280,000.00 0.00 2,217,280,000.00 303,917,000.00 151,000.00 303,766,000.00 212,000,000.00 91,766,000.00
2023-09-30T00:00:00 quarterly 0.00 51,120,346.00 51,120,346.00 764,100,000.00 935,300,000.00 11,911,200,000.00 12,855,700,000.00 1,207,900,000.00 11,911,200,000.00 28,100,000.00 11,948,500,000.00 11,948,500,000.00 11,948,500,000.00 11,948,500,000.00 11,846,200,000.00 0.00 0.00 102,300,000.00 102,300,000.00 3,735,200,000.00 798,600,000.00 0.00 0.00 42,700,000.00 8,300,000.00 630,300,000.00 22,300,000.00 22,300,000.00 0.00 95,000,000.00 2,936,600,000.00 68,900,000.00 913,000,000.00 5,800,000.00 907,200,000.00 0.00 35,000,000.00 1,499,000,000.00 0.00 0.00 1,499,000,000.00 15,683,700,000.00 11,539,200,000.00 77,800,000.00 0.00 40,900,000.00 40,900,000.00 37,300,000.00 37,300,000.00 11,321,300,000.00 0.00 11,321,300,000.00 3,331,800,000.00 7,989,500,000.00 0.00 0.00 0.00 0.00 4,144,500,000.00 255,400,000.00 0.00 0.00 0.00 1,524,900,000.00 0.00 0.00 0.00 0.00 0.00 1,100,000.00 0.00 2,200,300,000.00 0.00 0.00 162,800,000.00 19,700,000.00 143,100,000.00 0.00 0.00
2023-03-31T00:00:00 quarterly 0.00 51,100,628.00 51,100,628.00 682,928,000.00 877,452,000.00 11,653,336,000.00 12,544,118,000.00 1,464,677,000.00 11,653,336,000.00 22,598,000.00 11,689,264,000.00 11,689,264,000.00 11,689,264,000.00 11,689,264,000.00 34,601,000.00 10,993,320,000.00 188,898,000.00 102,279,000.00 102,279,000.00 4,229,866,000.00 688,126,000.00 0.00 93,092,000.00 8,117,000.00 9,044,000.00 559,611,000.00 18,262,000.00 18,262,000.00 0.00 93,100,000.00 3,541,740,000.00 2,889,000.00 859,190,000.00 4,336,000.00 854,854,000.00 42,605,000.00 34,500,000.00 2,554,329,000.00 646,704,000.00 10,463,000.00 1,897,162,000.00 15,919,130,000.00 10,912,713,000.00 27,109,000.00 108,986,000.00 0.00 40,600,000.00 35,928,000.00 35,928,000.00 10,675,942,000.00 -1,681,891,000.00 12,357,833,000.00 3,520,104,000.00 264,951,000.00 7,532,240,000.00 729,827,000.00 310,711,000.00 0.00 5,006,417,000.00 57,911,000.00 205,000.00 10,463,000.00 42,800,000.00 1,836,630,000.00 -1,910,000.00 76,063,000.00 784,376,000.00 81,720,000.00 896,381,000.00 2,489,000.00 299,760,000.00 2,584,212,000.00 0.00 2,584,212,000.00 171,947,000.00 21,000.00 171,926,000.00 96,000,000.00 75,926,000.00
2023-03-31T00:00:00 annual 0.00 51,100,628.00 51,100,628.00 682,928,000.00 877,452,000.00 11,653,336,000.00 12,544,118,000.00 1,464,677,000.00 11,653,336,000.00 22,598,000.00 11,689,264,000.00 11,689,264,000.00 11,689,264,000.00 11,689,264,000.00 34,601,000.00 10,993,320,000.00 188,898,000.00 102,279,000.00 102,279,000.00 4,229,866,000.00 688,126,000.00 0.00 93,092,000.00 8,117,000.00 9,044,000.00 559,611,000.00 18,262,000.00 18,262,000.00 0.00 93,100,000.00 3,541,740,000.00 2,889,000.00 859,190,000.00 4,336,000.00 854,854,000.00 42,605,000.00 34,500,000.00 2,554,329,000.00 646,704,000.00 10,463,000.00 1,897,162,000.00 15,919,130,000.00 10,912,713,000.00 27,109,000.00 108,986,000.00 0.00 40,600,000.00 35,928,000.00 35,928,000.00 10,675,942,000.00 -1,681,891,000.00 12,357,833,000.00 3,520,104,000.00 264,951,000.00 7,532,240,000.00 729,827,000.00 310,711,000.00 0.00 5,006,417,000.00 57,911,000.00 205,000.00 10,463,000.00 42,800,000.00 1,836,630,000.00 -1,910,000.00 76,063,000.00 784,376,000.00 81,720,000.00 896,381,000.00 2,489,000.00 299,760,000.00 2,584,212,000.00 0.00 2,584,212,000.00 171,947,000.00 21,000.00 171,926,000.00 96,000,000.00 75,926,000.00
2022-03-31T00:00:00 annual 0.00 51,072,447.00 51,072,447.00 0.00 232,886,000.00 9,880,185,000.00 10,125,339,000.00 2,096,622,000.00 9,880,185,000.00 5,606,000.00 9,898,059,000.00 9,898,059,000.00 9,898,059,000.00 9,898,059,000.00 32,892,000.00 9,234,668,000.00 165,037,000.00 102,223,000.00 102,223,000.00 3,815,267,000.00 536,130,000.00 81,000.00 34,316,000.00 12,016,000.00 12,639,000.00 472,232,000.00 4,927,000.00 4,927,000.00 0.00 34,300,000.00 3,279,137,000.00 14,665,000.00 227,959,000.00 679,000.00 227,280,000.00 73,817,000.00 66,200,000.00 2,899,805,000.00 604,796,000.00 10,319,000.00 2,284,690,000.00 13,713,326,000.00 8,337,567,000.00 27,107,000.00 532,238,000.00 0.00 40,800,000.00 17,874,000.00 17,874,000.00 7,698,053,000.00 -1,275,849,000.00 8,973,902,000.00 1,423,721,000.00 242,630,000.00 6,308,676,000.00 688,164,000.00 310,711,000.00 0.00 5,375,759,000.00 298,600,000.00 23,457,000.00 10,320,000.00 88,834,000.00 1,645,298,000.00 -788,000.00 123,124,000.00 805,636,000.00 96,639,000.00 620,687,000.00 14,968,000.00 210,048,000.00 2,767,442,000.00 0.00 2,767,442,000.00 615,392,000.00 236,753,000.00 378,639,000.00 313,900,000.00 64,739,000.00
2021-03-31T00:00:00 annual 0.00 51,031,777.00 51,031,777.00 0.00 470,774,000.00 7,910,293,000.00 8,389,138,000.00 2,461,224,000.00 7,910,293,000.00 6,217,000.00 7,924,581,000.00 8,140,505,000.00 7,924,581,000.00 7,924,581,000.00 28,160,000.00 7,653,337,000.00 145,110,000.00 102,142,000.00 102,142,000.00 3,528,765,000.00 710,777,000.00 0.00 39,006,000.00 36,534,000.00 0.00 413,714,000.00 221,523,000.00 5,599,000.00 215,924,000.00 39,006,000.00 2,817,988,000.00 4,967,000.00 249,251,000.00 618,000.00 248,633,000.00 74,543,000.00 67,806,000.00 2,444,658,000.00 644,780,000.00 10,187,000.00 1,789,691,000.00 11,453,346,000.00 6,174,134,000.00 27,107,000.00 125,078,000.00 8,753,000.00 8,753,000.00 14,288,000.00 14,288,000.00 5,942,347,000.00 -967,464,000.00 6,909,811,000.00 1,373,751,000.00 169,557,000.00 4,454,881,000.00 606,299,000.00 305,323,000.00 0.00 5,279,212,000.00 182,631,000.00 23,215,000.00 11,134,000.00 55,401,000.00 1,218,970,000.00 -1,451,000.00 75,264,000.00 462,399,000.00 67,396,000.00 615,362,000.00 9,259,000.00 129,731,000.00 2,279,861,000.00 0.00 2,279,861,000.00 1,551,641,000.00 590,200,000.00 961,441,000.00 656,725,000.00 304,716,000.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 537,872,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 479,348,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: ALKYLAMINE Cash Flow Data In (Cr)

date period_type Free Cash Flow Repayment Of Debt Issuance Of Debt Issuance Of Capital Stock Capital Expenditure End Cash Position Beginning Cash Position Changes In Cash Financing Cash Flow Net Other Financing Charges Interest Paid Cff Cash Dividends Paid Common Stock Dividend Paid Net Common Stock Issuance Common Stock Issuance Net Issuance Payments Of Debt Net Short Term Debt Issuance Short Term Debt Payments Net Long Term Debt Issuance Long Term Debt Payments Long Term Debt Issuance Investing Cash Flow Net Other Investing Changes Interest Received Cfi Dividends Received Cfi Net Investment Purchase And Sale Sale Of Investment Purchase Of Investment Net PPE Purchase And Sale Sale Of PPE Purchase Of PPE Capital Expenditure Reported Operating Cash Flow Taxes Refund Paid Change In Working Capital Change In Other Current Liabilities Change In Other Current Assets Change In Payable Change In Inventory Change In Receivables Other Non Cash Items Stock Based Compensation Provisionand Write Offof Assets Depreciation And Amortization Amortization Cash Flow Depreciation Gain Loss On Investment Securities Net Foreign Currency Exchange Gain Loss Gain Loss On Sale Of PPE Net Income From Continuing Operations
2024-03-31T00:00:00 annual 1,526,503,000.00 -3,421,237,000.00 2,572,755,000.00 8,221,000.00 -1,223,188,000.00 303,707,000.00 171,837,000.00 131,870,000.00 -1,403,170,000.00 8,100,000.00 -44,262,000.00 -511,139,000.00 0.00 8,221,000.00 8,221,000.00 -848,482,000.00 0.00 0.00 -848,482,000.00 -3,421,237,000.00 2,572,755,000.00 -1,214,651,000.00 -2,948,000.00 8,775,000.00 0.00 0.00 0.00 0.00 -1,220,478,000.00 2,710,000.00 -1,223,188,000.00 0.00 2,749,691,000.00 -345,672,000.00 402,935,000.00 -117,592,000.00 220,263,000.00 -178,162,000.00 116,975,000.00 365,291,000.00 32,819,000.00 11,026,000.00 0.00 589,225,000.00 5,462,000.00 583,763,000.00 0.00 1,437,000.00 -291,000.00 2,024,680,000.00
2023-03-31T00:00:00 annual -550,427,000.00 -736,223,000.00 1,351,787,000.00 12,395,000.00 -3,034,252,000.00 171,837,000.00 378,639,000.00 -206,802,000.00 79,919,000.00 4,400,000.00 -30,613,000.00 -510,919,000.00 0.00 12,395,000.00 12,395,000.00 615,564,000.00 0.00 0.00 615,564,000.00 -736,223,000.00 1,351,787,000.00 -2,770,546,000.00 236,853,000.00 22,423,000.00 0.00 0.00 0.00 0.00 -3,029,822,000.00 4,430,000.00 -3,034,252,000.00 0.00 2,483,825,000.00 -713,952,000.00 -427,469,000.00 26,248,000.00 -62,426,000.00 -387,528,000.00 -191,333,000.00 183,130,000.00 21,439,000.00 13,231,000.00 0.00 451,732,000.00 4,624,000.00 447,108,000.00 0.00 21,116,000.00 3,134,000.00 3,085,587,000.00
2022-03-31T00:00:00 annual -422,752,000.00 -227,594,000.00 0.00 6,969,000.00 -2,469,508,000.00 378,639,000.00 961,441,000.00 -582,802,000.00 -572,892,000.00 -4,145,000.00 -39,952,000.00 -306,370,000.00 0.00 6,969,000.00 6,969,000.00 -227,594,000.00 0.00 0.00 -227,594,000.00 -227,594,000.00 0.00 -2,056,666,000.00 51,972,000.00 35,743,000.00 0.00 317,231,000.00 517,231,000.00 -200,000,000.00 -2,461,612,000.00 7,896,000.00 -2,469,508,000.00 0.00 2,046,756,000.00 -743,897,000.00 -568,471,000.00 -48,881,000.00 -115,476,000.00 523,234,000.00 -426,328,000.00 -487,581,000.00 4,686,000.00 17,771,000.00 -612,000.00 347,522,000.00 4,378,000.00 343,144,000.00 -14,809,000.00 -17,388,000.00 8,640,000.00 3,021,147,000.00
2021-03-31T00:00:00 annual 2,078,390,000.00 -381,168,000.00 0.00 3,697,000.00 -1,561,062,000.00 961,441,000.00 312,386,000.00 649,055,000.00 -864,514,000.00 -8,792,000.00 -68,360,000.00 -408,091,000.00 0.00 3,697,000.00 3,697,000.00 -381,168,000.00 -121,890,000.00 -121,890,000.00 -381,168,000.00 -381,168,000.00 0.00 -2,125,883,000.00 -286,920,000.00 21,105,000.00 0.00 -299,985,000.00 0.00 -299,985,000.00 -1,560,083,000.00 979,000.00 -1,561,062,000.00 0.00 3,639,452,000.00 -1,011,586,000.00 289,578,000.00 317,713,000.00 -96,446,000.00 1,089,404,000.00 -382,316,000.00 -637,646,000.00 36,677,000.00 19,240,000.00 -416,000.00 290,635,000.00 2,740,000.00 287,895,000.00 -2,437,000.00 -811,000.00 11,643,000.00 4,006,929,000.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -442,610,000.00 0.00 0.00 0.00 -505,145,000.00 -505,145,000.00 0.00 0.00 0.00 0.00 0.00 0.00 5,956,000.00 342,827,000.00 342,827,000.00 0.00 0.00 0.00 0.00 -772,846,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -11,848,000.00 0.00 0.00 0.00 -334,372,000.00 0.00 0.00 0.00

NSE: ALKYLAMINE Income Statement Data In (Cr)

date period_type Tax Effect Of Unusual Items Tax Rate For Calcs Normalized EBITDA Total Unusual Items Total Unusual Items Excluding Goodwill Net Income From Continuing Operation Net Minority Interest Reconciled Depreciation Reconciled Cost Of Revenue EBITDA EBIT Net Interest Income Interest Expense Interest Income Normalized Income Net Income From Continuing And Discontinued Operation Total Expenses Rent Expense Supplemental Diluted Average Shares Basic Average Shares Diluted EPS Basic EPS Diluted NI Availto Com Stockholders Net Income Common Stockholders Otherunder Preferred Stock Dividend Net Income Net Income Including Noncontrolling Interests Net Income Continuous Operations Tax Provision Pretax Income Other Non Operating Income Expenses Special Income Charges Other Special Charges Write Off Impairment Of Capital Assets Net Non Operating Interest Income Expense Total Other Finance Cost Interest Expense Non Operating Interest Income Non Operating Operating Income Operating Expense Other Operating Expenses Depreciation And Amortization In Income Statement Amortization Depreciation Income Statement Selling General And Administration Selling And Marketing Expense General And Administrative Expense Rent And Landing Fees Gross Profit Cost Of Revenue Total Revenue Operating Revenue
2024-03-31T00:00:00 annual -0.73 0.00 268.12 -2.76 -2.76 148.87 58.92 788.26 265.36 206.44 -3.49 3.97 0.90 150.90 148.87 1,222.34 0.27 5.12 5.11 0.00 0.00 148.87 148.87 0.00 148.87 148.87 148.87 53.59 202.47 0.07 -2.76 0.15 0.00 2.60 -3.49 0.42 3.97 0.90 196.66 434.08 232.16 58.92 0.55 58.38 55.29 47.27 8.02 0.27 630.74 788.26 1,419.00 1,419.00
2023-03-31T00:00:00 annual -1.02 0.00 360.39 -3.93 -3.93 228.66 45.17 880.86 356.46 311.29 -2.29 2.73 1.03 231.57 228.66 1,353.30 0.11 5.12 5.11 0.00 0.00 228.66 228.66 0.00 228.66 228.66 228.66 79.90 308.56 0.27 -3.93 3.93 0.00 0.00 -2.29 0.59 2.73 1.03 303.59 472.44 259.59 45.17 0.46 44.71 81.90 73.76 8.14 0.11 776.03 880.86 1,656.89 1,656.89
2022-03-31T00:00:00 annual 0.16 0.00 338.77 0.62 0.62 224.90 34.75 853.38 339.39 304.64 0.89 2.53 4.17 224.43 224.90 1,231.49 0.21 5.12 5.11 0.00 0.00 224.90 224.90 0.00 224.90 224.90 224.90 77.22 302.11 0.06 -0.86 0.86 0.00 0.00 0.89 0.75 2.53 4.17 292.12 378.11 205.41 34.75 0.44 34.31 59.35 52.42 6.93 0.21 670.23 853.38 1,523.61 1,523.61
2021-03-31T00:00:00 annual -1.15 0.00 438.88 -4.36 -4.36 295.34 29.06 536.47 434.52 405.46 -3.67 4.77 2.66 298.55 295.34 817.46 0.25 5.11 5.10 0.00 0.00 295.34 295.34 0.00 295.34 295.34 295.34 105.35 400.69 0.20 -4.60 4.60 0.00 0.08 -3.67 1.56 4.77 2.66 405.66 280.99 136.40 29.06 0.27 28.79 32.95 27.40 5.56 0.25 686.65 536.47 1,223.12 1,223.12
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

FII & DII Data (In Cr)

Date FII Gross Purchase FII Gross Sales FII Net Purchase / Sales DII Gross Purchase DII Gross Sales DII Net Purchase / Sales
2025-02-03 12,505.92 16,464.29 -3,958.37 19,319.48 16,611.25 2,708.23
2025-01-30 10,513.63 15,096.58 -4,582.95 13,934.35 11,768.46 2,165.89
2025-01-29 7,644.40 10,230.83 -2,586.43 12,871.38 11,078.67 1,792.71
2025-01-27 9,488.57 14,504.03 -5,015.46 16,503.43 9,861.28 6,642.15
2025-01-24 11,230.47 13,988.96 -2,758.49 12,835.41 10,433.10 2,402.31
2025-01-23 13,316.55 18,779.07 -5,462.52 14,412.73 10,700.18 3,712.55
2025-01-22 12,936.64 16,962.89 -4,026.25 15,437.18 11,796.96 3,640.22
Quarterly Results
Profit & Loss
Piotroski F-Score
5/9
0 1 2 3 4 5 6 7 8 9

Key Metrics

EPS

32.77

P/E

57.157463

P/B

7.3014283

Dividend Yield

0.53%

Market Cap

9,578.03 Cr.

Face Value

256.532

Book Value

256.532

ROE

11.26%

EBITDA Growth

285.02 Cr.

Debt/Equity

0.17

Short Term

Subscribe to unlock this feature

Medium Term

Subscribe to unlock this feature

Long Term

Subscribe to unlock this feature

Yearly Stock Performance Heatmap

Latest Updates

ALKYLAMINE News

Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI

Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:50

ALKYLAMINE News

Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends

"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:47

ALKYLAMINE News

FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore

Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:37

ALKYLAMINE News

Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal

The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:23

ALKYLAMINE News

Apple iPhone SE 4: Price To Features, 11 Things You Need To Know

iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:12

ALKYLAMINE News

Rupee Closed Weaker Against The US Dollar

The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 15:54

ALKYLAMINE News

Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45

Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:09

ALKYLAMINE News

War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel

The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:00

Popular Questions

How to Buy alkylamine Shares on Fincept?

You can buy Alkyl Amines Chemicals Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.

What is the Market Cap of alkylamine?

The market capitalization of Alkyl Amines Chemicals Limited is ₹9,578 Cr as of 05 Feb 2025.

What are the PE and PB ratios of Alkyl Amines Chemicals Limited?

The PE and PB ratios of Alkyl Amines Chemicals Limited are Not Available and 7.3014283 respectively as of 05 Feb 2025.

What is the 52 Week High of Alkyl Amines Chemicals Limited?

The 52-week high of Alkyl Amines Chemicals Limited is ₹2735 as of 05 Feb 2025.

What is the 52 Week Low of Alkyl Amines Chemicals Limited?

The 52-week low of Alkyl Amines Chemicals Limited is ₹1808 as of 05 Feb 2025.

What are the earnings per share (EPS) for Alkyl Amines Chemicals Limited?

The Earnings Per Share (EPS) of Alkyl Amines Chemicals Limited is ₹32.77 as per the most recent quarterly results available on Fincept.

What is the ROE (Return on Equity) of Alkyl Amines Chemicals Limited?

The Return on Equity (ROE) of Alkyl Amines Chemicals Limited is 11.26% as per the most recent financial year data. Explore more on Fincept.

TIPSINDLTD

View Stock

HAPPYFORGE

View Stock

MAXESTATES

View Stock

SARDAEN

View Stock

CELLO

View Stock

TECILCHEM

View Stock

BHANDA-RE1

View Stock

TEXINFRA

View Stock

CMSINFO

View Stock

BLUEJET

View Stock

VMART

View Stock

EXXARO

View Stock

SUNFLAG

View Stock

STARTECK

View Stock

ROSSELLIND

View Stock